Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC
Conditions:   Tislelizumab;   Chemotherapy;   First-line;   Gastric Cancer Stage IV Intervention:   Drug: Tislelizumab Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

COMPETE Cohort Study
Conditions:   PFO - Patent Foramen Ovale;   Migraine Intervention:   Device: PFO occlusion Sponsor:   Chinese Academy of Medical Sciences, Fuwai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Applications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery Preservation
Conditions:   Fluorescence;   Indocyanine Green;   Rectal Cancer Surgery Intervention:   Device: Fluorescence laparoscopic system Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions:   Gastric Cancer;   Image;   Pathology Intervention:   Drug: Neoadjuvant Chemotherapy Sponsors:   Chinese Academy of Sciences;   Peking University Cancer Hospital & Institute;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences;   Yunnan Cancer Hospital;   Henan Cancer Hospital;   Zhenjiang First People's Hospital;   First Hospital of China Medical University;   Cancer Hospital of Guangxi Medical University;   Peking  University People's Hospital;   Tianjin Medical University Cancer Institute and Hospital;   The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC
Conditions:   Tislelizumab;   Chemotherapy;   First-line;   Gastric Cancer Stage IV Intervention:   Drug: Tislelizumab Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions:   Gastric Cancer;   Image;   Pathology Intervention:   Drug: Neoadjuvant Chemotherapy Sponsors:   Chinese Academy of Sciences;   Peking University Cancer Hospital & Institute;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences;   Yunnan Cancer Hospital;   Henan Cancer Hospital;   Zhenjiang First People's Hospital;   First Hospital of China Medical University;   Cancer Hospital of Guangxi Medical University;   Peking  University People's Hospital;   Tianjin Medical University Cancer Institute and Hospital;   The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC
Conditions:   Tislelizumab;   Chemotherapy;   First-line;   Gastric Cancer Stage IV Intervention:   Drug: Tislelizumab Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Applications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery Preservation
Conditions:   Fluorescence;   Indocyanine Green;   Rectal Cancer Surgery Intervention:   Device: Fluorescence laparoscopic system Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials

COMPETE Cohort Study
Conditions:   PFO - Patent Foramen Ovale;   Migraine Intervention:   Device: PFO occlusion Sponsor:   Chinese Academy of Medical Sciences, Fuwai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials

Applications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery Preservation
Conditions:   Fluorescence;   Indocyanine Green;   Rectal Cancer Surgery Intervention:   Device: Fluorescence laparoscopic system Sponsor:   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials

Antecubital Versus Femoral Approach for Adrenal Venous Sampling
Condition:   Hyperaldosteronism Interventions:   Procedure: Adrenal Venous Sampling via Antecubital Approach;   Procedure: Adrenal Venous Sampling via Femoral Approach Sponsor:   Chinese Academy of Medical Sciences, Fuwai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials